Reference pricing models are emerging as increasingly popular approaches for lowering drug costs.
Pharmacy Best Practices
We asked several healthcare executives what they are hearing their colleagues talk about the most. Here’s what they said.
Trust in the healthcare sector is dropping, a warning sign to executives. Here’s four ways how to reclaim it.
To identify the top managed care pharmacy challenges and what your peers are doing about them, Managed Healthcare Executive conducted its annual pharmacy survey during the first quarter of 2018.
The International Rare Diseases Research Consortium hopes to develop 200 new drugs for rare diseases by 2020, and it seems as if things are better than on track.
Some of the most amazing things are happening in the delivery of medical care these days. Surgical techniques, new devices, drugs, and diagnostics can treat and cure many medical conditions.
Congress recently began hearings on proposals to combat opioid abuse. Our policy analyst weighs in.
Experts say this new migraine medication, the first in 50 years, shows great promise. Here’s what you need to know, including the cost implications
A new study sheds light on PDMPs and their effectiveness in tackling the opioid crisis and includes one disturbing finding you won’t believe.
The new Bipartisan Budget Act of 2018, to be in effect on January 2019, institutes new reimbursement guidelines for biosimilars under the Medicare coverage gap discount program that remove disincentives for biosimilar uptake and level the playing field for the future market place.